The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease or GERD. The agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback